| Početna strana | Uredništvo | Časopis  | Uputstvo autorima  | Kodeks u  kliničkom i eksperimentalnom radu | Kontakt  |  
| Home page | Editorial  board | About the Journal | Instructions for Authors | Peer Review Policy | Clinical and Experimental Work Code | Contact  |


Acta Medica Medianae
Vol. 50, No 1, March, 2011

UDK 61
ISSN 0365-4478(Printed version)
ISSN 1821-2794(Online)


Correspondence to:

Dragoslav Bašić

Urology Clinic, Clinical Center Niš

Bulevar Zorana Đinđića 48

18000 Niš, Serbia

E-mail: drbasic@ptt.rs





Case report
UDC: 616.61-089.84-078

DOI: 10.5633/amm.2011.0110






Dragoslav Bašić1, Ljubomir Đurašić2, Bratislav Bašić3, Marica Bašić4, Drago Milutinović5, Milan Đokić5 and Jovan Hadži Đokić5



                       Urology Clinic, Clinical Center Niš, Niš, Serbia1

                       Institute of Physical Medicine and Rehabilitation, Clinical Center of Serbia, Belgrade, Serbia2

                       Berlin - Chemie Menarini, Belgrade, Serbia3

                       Research Center, Clinical Center of Serbia, Belgrade, Serbia4

                       Institute of Urology and Nephrology, Clinical Center of Serbia, Belgrade, Serbia5



Surgicel (Johnson & Johnson Medical, New Brunswick, NJ) represents well-known surgical haemostatic material. This report presents a case of a 36-year-old female patient who had postoperative extrinsic kidney allograft obstruction secondary to Surgicel. The patient presented with fever, pain in the perigraft region and hydronephrosis. After diagnostic procedure, a reexploration along with surgical removal of Surgicel was performed. The operative outcome was excellent. Acta Medica Medianae 2011;50(1):51-53.


Key words: surgicel, kidney, allograft obstruction